These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Development of novel immunoglobulin G (IgG), IgA, and IgM enzyme immunoassays based on recombinant Puumala and Dobrava hantavirus nucleocapsid proteins. Meisel H, Wolbert A, Razanskiene A, Marg A, Kazaks A, Sasnauskas K, Pauli G, Ulrich R, Krüger DH. Clin Vaccine Immunol; 2006 Dec; 13(12):1349-57. PubMed ID: 17021245 [Abstract] [Full Text] [Related]
7. [Grading the severity of disease in patients with Puumala or Dobrava virus infections from 1995 to 2000 in Croatia]. Cebalo L, Dusek T, Kuzman I, Markotić A. Acta Med Croatica; 2003 Dec; 57(5):355-9. PubMed ID: 15011460 [Abstract] [Full Text] [Related]
10. Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses. de Carvalho Nicacio C, Gonzalez Della Valle M, Padula P, Björling E, Plyusnin A, Lundkvist A. J Virol; 2002 Jul; 76(13):6669-77. PubMed ID: 12050380 [Abstract] [Full Text] [Related]
11. Truncated hantavirus nucleocapsid proteins for serotyping Hantaan, Seoul, and Dobrava hantavirus infections. Araki K, Yoshimatsu K, Ogino M, Ebihara H, Lundkvist A, Kariwa H, Takashima I, Arikawa J. J Clin Microbiol; 2001 Jul; 39(7):2397-404. PubMed ID: 11427545 [Abstract] [Full Text] [Related]
13. Use of recombinant nucleocapsid proteins of the Hantaan and nephropathia epidemica serotypes of Hantaviruses as immunodiagnostic antigens. Zöller L, Yang S, Gött P, Bautz EK, Darai G. J Med Virol; 1993 Mar; 39(3):200-7. PubMed ID: 8096868 [Abstract] [Full Text] [Related]
15. Comprehensive computational analysis reveals YXXΦ[I/L/M/F/V] motif and YXXΦ-like tetrapeptides across HFRS causing Hantaviruses and their association with viral pathogenesis and host immune regulation. Noor F, Ashfaq UA, Asif M, Adeel MM, Alshammari A, Alharbi M. Front Immunol; 2022 Mar; 13():1031608. PubMed ID: 36275660 [Abstract] [Full Text] [Related]
18. [Prevalence of antibodies to hantavirus among hemodialysis patients with end-stage renal failure in Kaunas and its district]. Dargevicius A, Petraityte R, Sribikiene B, Sileikiene E, Razukeviciene L, Ziginskiene E, Vorobjoviene R, Razanskiene A, Sasnauskas K, Bumblyte IA, Kuzminskis V. Medicina (Kaunas); 2007 Mar; 43 Suppl 1():72-6. PubMed ID: 17551280 [Abstract] [Full Text] [Related]
19. Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients--implications for treatment. Pettersson L, Thunberg T, Rocklöv J, Klingström J, Evander M, Ahlm C. Clin Microbiol Infect; 2014 Mar; 20(3):235-41. PubMed ID: 23742660 [Abstract] [Full Text] [Related]
20. HLA-associated hemorrhagic fever with renal syndrome disease progression in slovenian patients. Korva M, Saksida A, Kunilo S, Vidan Jeras B, Avsic-Zupanc T. Clin Vaccine Immunol; 2011 Sep; 18(9):1435-40. PubMed ID: 21775516 [Abstract] [Full Text] [Related] Page: [Next] [New Search]